Your browser doesn't support javascript.
loading
Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
Chytil, Petr; Sírová, Milada; Kudlácová, Júlia; Ríhová, Blanka; Ulbrich, Karel; Etrych, Tomás.
Afiliação
  • Chytil P; Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského námestí 2 , 162 06 Prague 6 , Czech Republic.
  • Sírová M; Institute of Microbiology, Czech Academy of Sciences , Vídenská 1083 , 142 20 Prague 4 , Czech Republic.
  • Kudlácová J; Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského námestí 2 , 162 06 Prague 6 , Czech Republic.
  • Ríhová B; Institute of Microbiology, Czech Academy of Sciences , Vídenská 1083 , 142 20 Prague 4 , Czech Republic.
  • Ulbrich K; Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského námestí 2 , 162 06 Prague 6 , Czech Republic.
  • Etrych T; Institute of Macromolecular Chemistry, Czech Academy of Sciences , Heyrovského námestí 2 , 162 06 Prague 6 , Czech Republic.
Mol Pharm ; 15(9): 3654-3663, 2018 09 04.
Article em En | MEDLINE | ID: mdl-29543465
ABSTRACT
Herein, the biodegradable micelle-forming amphiphilic N-(2-hydroxypropyl) methacrylamide (HPMA)-based polymer conjugates with the anticancer drug doxorubicin (Dox) designed for enhanced tumor accumulation were investigated, and the influence of their stability in the bloodstream on biodistribution, namely, tumor uptake, and in vivo antitumor efficacy were evaluated in detail. Dox was attached to the polymer carrier by a hydrazone bond enabling pH-controlled drug release. While the polymer-drug conjugates were stable in a buffer at pH 7.4 (mimicking bloodstream environment), Dox was released in a buffer under mild acidic conditions modeling the tumor microenvironment or cells. The amphiphilic polymer carriers differed in the structure of hydrophobic cholesterol derivative moieties bound to the HPMA copolymers via a hydrolyzable hydrazone bond, exhibiting different rates of micellar structure disintegration at various pH values. Considerable dependence of the studied polymer-drug conjugate biodistribution on the stability of the micellar structure was observed in neutral, bloodstream-mimicking, environment, showing that a faster rate of the micelle disintegration in pH 7.4 increased the conjugate blood clearance, decreased tumor accumulation, and significantly reduced the tumorblood and tumormuscle ratios. Similarly, the final therapeutic outcome was strongly affected by the stability of the micellar structure because the most stable micellar conjugate showed an almost similar therapeutic outcome as the water-soluble, nondegradable, high-molecular-weight starlike HPMA copolymer-Dox conjugate, which was highly efficient in the treatment of solid tumors in mice. Based on the results, we conclude that the bloodstream stability of micellar polymer-anticancer drug conjugates, in addition to their low side toxicity, is a crucial parameter for their efficient solid tumor accumulation and high in vivo antitumor activity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros / Doxorrubicina Limite: Animals Idioma: En Revista: Mol Pharm Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros / Doxorrubicina Limite: Animals Idioma: En Revista: Mol Pharm Ano de publicação: 2018 Tipo de documento: Article